Recombinant human granulocyte/macrophage colony-stimulating factor (NCPC GeneTech Biotechnology)

注射用重组人粒细胞巨噬细胞集落刺激因子

Report date: 2022/01/14 13:23:58

Base Information

Drug NameRecombinant human granulocyte/macrophage colony-stimulating factor (NCPC GeneTech Biotechnology)
Drug Alias NameHuaBei Jimuxin华北吉姆欣
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionHaematopoiesis stimulantsGranulocyte-macrophage colony-stimulating factor receptor modulators
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeutropenia
Global Approved IndicationsNeutropenia
Approved Indications in ChinaNeutropenia
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNcpc Genetech Biotechnology DevelopmentNorth China Pharmaceutical Company Ltd
China Registration ClassN/A

Develop Information

Active CompaniesNcpc Genetech Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsNeutropenia
Inactive IndicationsN/A

Other Information

ATC CodeL03AA02
Related LinksN/A